Wanted: Bigger Slice for Biomedicine

WASHINGTON—There are two ways for biomedical research to receive more federal funds: from new money generated by raising taxes, or through a larger share of the existing budget. While the biomedical commnunity as a whole is just beginning to tackle the problem, one group—the American Federation for Clinical Researchers—has already decided that biomedical research should receive a larger slice of the current pie at the expense of military research. On March 3 the New Jersey-

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—There are two ways for biomedical research to receive more federal funds: from new money generated by raising taxes, or through a larger share of the existing budget.

While the biomedical commnunity as a whole is just beginning to tackle the problem, one group—the American Federation for Clinical Researchers—has already decided that biomedical research should receive a larger slice of the current pie at the expense of military research. On March 3 the New Jersey-based organization made its point with 535 apple pies, one for each member of the House and Senate.

“Our message is, it matters how you slice it,” said federation president David Hathaway of Indiana University at a press conference in the Capitol. “By giving the military two-thirds of the federal R&D budget, the government is failing to respond to the public’s interest in increased support for biomedical research and limiting growth in an era of very ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo